Shizuoka, Japan

Akinori Hamaguchi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kyowa Hakko Kirin Co., Limited. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akinori Hamaguchi. Retrieved from https://idiyas.com/inventor/akinori-hamaguchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akinori Hamaguchi: Innovator in Tricyclic Compounds

Introduction

Akinori Hamaguchi is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on tricyclic compounds. His research and inventions have the potential to impact various therapeutic areas.

Latest Patents

Akinori Hamaguchi holds a patent for a PPAR γ agonist that comprises a tricyclic compound represented by a specific formula. This invention includes various structural components, such as lower alkyl groups and pharmaceutically acceptable salts. The patent highlights the potential applications of these compounds in medical treatments.

Career Highlights

Akinori Hamaguchi is associated with Kyowa Hakko Kirin Co., Limited, a company known for its advancements in biotechnology and pharmaceuticals. His work has contributed to the company's reputation as a leader in innovative drug development.

Collaborations

Akinori has collaborated with notable colleagues, including Arata Yanagisawa and Takeshi Kuboyama. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Akinori Hamaguchi's contributions to the field of tricyclic compounds exemplify the importance of innovation in pharmaceuticals. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…